CN105876783A - 一种铁皮石斛花组合物及其制法和保肝解酒制品 - Google Patents
一种铁皮石斛花组合物及其制法和保肝解酒制品 Download PDFInfo
- Publication number
- CN105876783A CN105876783A CN201610218622.0A CN201610218622A CN105876783A CN 105876783 A CN105876783 A CN 105876783A CN 201610218622 A CN201610218622 A CN 201610218622A CN 105876783 A CN105876783 A CN 105876783A
- Authority
- CN
- China
- Prior art keywords
- flower
- flos
- flowers
- herba dendrobii
- goods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 150000001875 compounds Chemical class 0.000 title abstract description 9
- 208000007848 Alcoholism Diseases 0.000 title abstract description 4
- 201000007930 alcohol dependence Diseases 0.000 title abstract description 4
- 241000026010 Dendrobium candidum Species 0.000 title abstract 10
- 239000000203 mixture Substances 0.000 claims abstract description 87
- 241000628997 Flos Species 0.000 claims abstract description 78
- 239000002994 raw material Substances 0.000 claims abstract description 35
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 13
- 229960003080 taurine Drugs 0.000 claims abstract description 12
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 8
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 8
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 8
- 235000013361 beverage Nutrition 0.000 claims description 22
- 239000002775 capsule Substances 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 241000196324 Embryophyta Species 0.000 claims description 9
- 235000009508 confectionery Nutrition 0.000 claims description 9
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 230000037396 body weight Effects 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 8
- 244000183685 Citrus aurantium Species 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 5
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 230000008719 thickening Effects 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 230000006378 damage Effects 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 19
- 230000006870 function Effects 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 4
- 241000219071 Malvaceae Species 0.000 abstract description 2
- 241000220317 Rosa Species 0.000 abstract description 2
- 240000000559 Albizia odoratissima Species 0.000 abstract 1
- 235000011438 Albizia odoratissima Nutrition 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000208296 Datura Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 241000132446 Inula Species 0.000 abstract 1
- 240000006859 Jasminum officinale Species 0.000 abstract 1
- 235000010254 Jasminum officinale Nutrition 0.000 abstract 1
- 235000019082 Osmanthus Nutrition 0.000 abstract 1
- 241000333181 Osmanthus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000046101 Sophora japonica Species 0.000 abstract 1
- 235000010586 Sophora japonica Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 42
- 238000000034 method Methods 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 229930003944 flavone Natural products 0.000 description 8
- 235000011949 flavones Nutrition 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 7
- -1 flavone compound Chemical class 0.000 description 7
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000035622 drinking Effects 0.000 description 6
- 206010067125 Liver injury Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 150000002212 flavone derivatives Chemical class 0.000 description 5
- 231100000753 hepatic injury Toxicity 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 239000000341 volatile oil Chemical class 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical group 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 229930009674 sesquiterpene lactone Natural products 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- KMOUJOKENFFTPU-UHFFFAOYSA-N Apigenin-7-glucosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 KMOUJOKENFFTPU-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000189115 Catananche Species 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 235000002548 Cistus Nutrition 0.000 description 1
- 241000984090 Cistus Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- ACBOFPQSBWBAQR-UHFFFAOYSA-N Cosmosiin Natural products OCC1OC(Oc2cc(O)c3C(=O)C=C(Oc3c2)c4cccc(O)c4)C(O)C(O)C1O ACBOFPQSBWBAQR-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241001076416 Dendrobium tosaense Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 240000003537 Ficus benghalensis Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 241000207840 Jasminum Species 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 241001327284 Sorghastrum nutans Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002075 anti-alcohol Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- KMOUJOKENFFTPU-QNDFHXLGSA-N apigenin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 KMOUJOKENFFTPU-QNDFHXLGSA-N 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000020342 bubble tea Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000009472 lonicerae flos Substances 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 230000007863 steatosis Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种铁皮石斛花组合物及其制法和保肝解酒制品,所述铁皮石斛花组合物的成分包括铁皮石斛花、葛花、菊花、密蒙花、合欢花、槐花、栀子花、素馨花、洋金花、金银花、玫瑰花、旋覆花、三七花、桃花、桂花、木棉花、玳玳花、牛磺酸、糖粉及抗坏血酸。本发明还公开了多种利用该铁皮石斛花组合物制备的制品及其各自的制法。本发明的产品充分发挥铁皮石斛花的独特功效,并对我国传统花类药材和花类原料进行合理充分的利用,制成品具有良好的保肝解酒功效。
Description
技术领域
本发明涉及功能食品的技术领域,具体地,本发明涉及一种铁皮石斛花组合物及其制法和由其制成的产品。
背景技术
酒是人们常见的饮品,特别在节日、聚会、宴请等场合会较多饮用,人们经常出现饮酒过多的情况,造成肝脏、胃等器官的负担,同时出现头晕、呕吐等症状,给饮酒后短期的生活状态造成较大的影响。铁皮石斛植物花具有多种不同的功效,包括护肝和醒酒等,基于保肝和解酒的需求,以铁皮石斛植物花为主要原料的保肝解酒产品具有新颖、实用和良好的保肝解酒效果。相关植物花原料的成分和药理作用如下所述。
铁皮石斛花为铁皮石斛(Dendrobium officinale Kimura etMigo)所开的花。因铁皮石斛具有良好的益胃生津,滋阴清热功能,具有保肝解酒的功效。铁皮石斛花含有大量的精氨酸,对维护肠道粘膜完整性起到重要的作用;同时含有较多的黄酮类成分,显示了良好的抗氧化作用(龚庆芳等,铁皮石斛花化学成分及抗氧化活性研究,食品科技,2014,39(12):106-110);另有研究表明,铁皮石斛花可能通过影响甲状腺素物质代谢,改善微循减慢心率而产生滋阴护肝作用(雷珊珊等,铁皮石斛花提取物对甲亢型阴虚小鼠的影响,2015,40(9):1793-1797)。因而具有潜在的保肝解酒效果。
葛花为“药食同源”植物葛根的花,葛花的主要有效成分为黄酮类化合物、挥发油类化合物、皂苷类化合物、甾醇类、生物碱、氨基酸等。葛花具有解酒保肝的作用,同时能够起到降低血糖血脂、保护心肌、抗诱变、抗过敏、改善学习记忆力等的作用,特别是能显著提高小鼠肝脏乙醇脱氢酶的活性[刘连起等,醉酒灵对急性酒精中毒作用的实验研究,北京中医药大学学报,1998,21(3):24-25],具有明显的预防酒精性肝损伤的作用[苗彦妮等,葛花对大鼠酒精性肝损伤的预防作用研究,科技导报,2008,26(15):60-65]。
菊花为多年生菊科草本植物,含有水苏碱、木樨草甙、大波斯菊甙、腺膘呤、胆碱、葡萄糖甙等成分,尤其富含挥发油,并且油中主要为菊酮、龙脑、龙脑已酸酯等物质。菊花性甘、微寒,具有散风热、平肝明目、消咳止痛的功效,用于治疗头痛眩晕、目赤肿痛、风热感冒、咳嗽等病症效果显著,还具有提神醒脑的功效。研究表明具有抗氧化的作用[黄秀榕等,四种归肝经明目中药防护晶状体氧化损伤和上皮细胞凋亡的研究,2004,9(4):441-446]。
密蒙花为中国药典收载药品常用中药,其有效部位为黄酮类物质,既能清肝,又能养肝,为厥阴肝经之正药,具有去目中赤脉,祛翳明目的作用,《开宝本草》中载其“味甘,平,微寒,入肝经”。
金银花为忍冬科忍冬属多年生常绿植物忍冬的干燥花蕾,主要化学成分为有机酸类化合物、糖类化合物、黄酮类化合物、挥发油、萜类化合物和微量元素等。金银花具有抑菌抗病毒的作用,也具有清热解毒、保肝利胆、抗过敏、抗肿瘤、清除自由基、抗氧化,增强免疫力、调节血脂、降血压等的功效,对治疗头痛、泻痢、呼吸道感染、热病等多种疾病有显著效果,同时对心血管等的疾病也有明显的治疗效果。研究表明,金银花提取液可起到降低小白鼠醉酒率的作用,使小白鼠醉酒耐受时间有所延长,醒酒时间有所缩短[周建华等,金银花葛花和蜂蜜复合口服液对小白鼠解酒作用的研究,食品研究与开发,2014,35(14):16-18]。
素馨花为木犀花科植物素馨(Jasminum offlcinale Linn.Var grardiflorum(Linn)Kobuski)的干燥花蕾或已开放的花,又名君召针,其性味甘,平,归肝经。具有舒肝解郁之功。临床可用于治疗肝郁气痛,心胃气痛,下痢腹痛。素馨花还具有护肤美容之功,亦有人在临床中用于治疗肝癌、胃癌、肠癌引起的疼痛,尚可用于治疗多种原因引起的贫血疗效显著。最近研究表明具有良好的抗肝脏病毒的功效[王宏伟,素馨花中的酚类抗HBV活性成分研究,2013年3,承德医学院硕士论文]。
三七花性味甘凉,具有清热、平肝、降压之功效,含有皂苷、黄酮、多糖等多种有效成分,具有较好的药用价值和保健作用。以三七花为主要成分研制的三七花含片可减轻酒精性肝损伤大鼠的肝组织脂肪变性,对酒精性肝损伤具有保护作用[王彦武等,三七花含片对酒精性肝损伤保护作用的实验研究,广西医科大学学报,2005,2:62-63]
合欢花含有黄酮等多种活性成分;玳玳花为芸香科植物玳玳花的干燥花蕾,又称香橼花,味甘、微苦,性平,归肝、胃经,具有理气宽胸、开胃止呕等功效,临床常用于胸脘胀闷、恶心呕吐、食欲不振等症。
旋覆花主要有黄酮类、倍半萜内酯类、多糖和萜类化合物,其中证明有药理活性的成份大多数为倍半萜内酯类化合物,具有抗炎、抗肝炎、抗肝损伤、抗肿瘤和细胞毒等作用。
玫瑰花性温味甘、微苦,入肝、脾经,具有行气解郁,和血止痛的功效,是常用的理气药,现代研究表明,玫瑰鲜花主要含有挥发油,此外还有槲皮甙、苦味素、鞣质、脂肪油、没食子酸、蜡质等成分,多用于肝胃气痛,食少呕恶等病症。
木棉花为木棉科植物木棉的干燥花,别名攀枝花、斑芝花性味甘,凉。具有清热利湿,解毒,止血的功效。主治肠炎、泄泻、痔疮出血、细菌性痢疾,具有清热解毒,疏肝利胆、化瘀的功效。
桂花是我国一种名贵花木,其花气味清香,有很好食用与药用价值。研究表明桂花中含有丰富的蛋白质、黄酮和维生素等物质,具有明显的抗氧化、降血糖、降血脂、抗菌、抗炎、增强机体免疫力等生理活性作用。
槐花含有黄酮、多糖等多种有效成分,具有提高免疫力、抗氧化等多种功能;栀子花含有黄酮,精油等成分,均有一定的健康功能。
牛磺酸(taurine)又名牛黄酸、牛胆酸等,在哺乳动物的脑、心、肝、肾等组织器官中含量丰富,是体内含量最高的游离氨基酸。牛磺酸作为一种营养物质能够参与机体的生长代谢,且参与维持机体的免疫功能,对神经、消化、生殖、心血管、免疫和内分泌等生理功能的正常发挥具有重要的调节作用。
抗坏血酸是水溶性的抗氧化剂,具有赋予产品酸味和抗氧化的作用,延长产品保质期,同时具有提高人体免疫力的功效。
目前具有针对保肝和解酒的产品开发,其中包括使用一些中草药和其他药食同源的原料,但以植物花为主要植物原料的相关产品比较少见,特别是具有保肝和解酒的花类原料均具有一种或者多种功效性成分,保肝解酒效果明显但市场上尚属空白,本发明的主要任务开发一种具有保肝和解酒功能的铁皮石斛花组合物及其制法并由其制的的主要产品和主要产品的制法。
发明内容
发明目的:针对现有技术的不足,本发明提供一种铁皮石斛花组合物及其制法和保肝解酒制品,充分发挥铁皮石斛花的独特功效,并对我国传统花类药材和花类原料进行合理充分的利用,制成品具有良好的保肝解酒功效。
技术方案:为了实现上述发明目的,本发明所采用的技术方案如下:
本发明的主要目的是提供一种铁皮石斛花组合物,所述铁皮石斛花组合物包括铁皮石斛花、葛花、菊花、密蒙花、合欢花、槐花、栀子花、素馨花、洋金花、金银花、玫瑰花、旋覆花、三七花、桃花、桂花、木棉花、玳玳花、牛磺酸、糖粉及抗坏血酸。
各原料组分按重量比计量如下:
铁皮石斛花10-50%,
葛花5-30%,
菊花5-30%,
密蒙花5-30%,
合欢花5-30%,
槐花5-30%,
栀子花1-5%,
素馨花1-15%,
洋金花1-15%,
金银花1-15%,
玫瑰花1-15%,
旋覆花1-5%,
三七花1-5%,
桃花1-5%,
桂花1-15%,
木棉花1-15%,
玳玳花1-15%,
牛磺酸0.2-2%,
糖粉5-20%,
抗坏血酸1-5%。
本发明提供两种优选的配方组成,
配方1:按100g质量计,所述铁皮石斛花组合物各组分构成如下:
配方2:按100g质量计,所述铁皮石斛花组合物各组分构成如下:
本发明另一个任务是提供铁皮石斛花组合物的制备方法,所述制备方法包括以下步骤:
a、按配方1或2的质量比称取各种干花类原料,将各种干花类原料充分混合备用,鲜花类原料则先在60℃温度环境下,减压烘干,再按照配方1或2的质量比称取,混匀备用;
b、将步骤a中混合得到后的干品原料混合物用中药粉碎机进行粉碎,粉碎时间2-10分钟,过80目筛,得到混合原料干粉备用;
c、按配方1或2的质量比称取牛磺酸、糖粉和抗坏血酸3种原料,加入到步骤b中得到的混合原料干粉中,进行充分混合,得到铁皮石斛花组合物。
进一步地,本发明采用的各个花类原料的进一步的限定如下:所述铁皮石斛花、葛花、菊花、密蒙花、合欢花、槐花、栀子花、素馨花、洋金花、金银花、玫瑰花、旋覆花、三七花、桃花、桂花、木棉花及玳玳花为各种植物花的干花,没有虫蛀、腐烂特征,符合食品、药品原料要求。
本发明中所述糖粉为白糖粉、红糖粉、黑糖粉及冰糖粉中的一种或者任意种的组合。
本发明的另一个任务是提供保肝解酒制品,所述保肝解酒制品中的主要添加物为铁皮石斛花组合物。本发明提供的保肝解酒制品列举如下:袋泡茶制品、胶囊制品、片剂制品、饮料制品、口服液制品、浸膏制品和冲剂制品。
各个制品的制法如下:
将铁皮石斛花组合物装入茶包袋后封口,每包装入1-3克,制得袋泡茶制品;
将铁皮石斛花组合物灌入胶囊,每个囊粒灌入0.3克混合物,制得胶囊制品;
向铁皮石斛花组合物中加入铁皮石斛花组合物本体重量的10-20%的麦芽糊精、0.1-1%的硬脂酸镁,充分混合后进行压片,制得片剂制品;
向铁皮石斛花组合物中加入铁皮石斛花组合物本体重量的5-10倍量的纯净水,加热搅拌浸提30-60分钟,温度50-100℃,提取并过滤后,制得饮料制品;
将上述饮料制品经减压浓缩后,制得口服液制品,进一步浓缩增稠轴,得到浸膏制品;
将上述饮料制品进行喷雾干燥或浸膏制品进行冻干、粉碎,制得冲剂制品。
有益效果:本发明与现有技术相比,其有益效果是:
本发明充分发挥铁皮石斛花的独特功效,并对我国传统花类药材和花类原料进行合理充分的利用,制得的组合物及其制品对醒酒解酒有显著的功效,有明显的保肝作用。
本发明进行的醒酒试验如下:
选取男性志愿者6名,年龄在40-60岁之间,在饮用52度白酒各半斤后,3人出现呕吐较大反应,2人出现头晕症状,1人出现轻微头晕反应。给予6人每人2袋本发明制得的袋泡茶,每袋用温水200mL冲泡后饮下,间隔1小时饮用1袋。6名志愿者在2小时内均出现良好反应,醒酒效果明显。
在后续对比试验中,先给予志愿者每人2袋本发明制得的袋泡茶,在饮酒前服下,服用半斤白酒后,志愿者均表示饮酒反应较未饮用袋泡茶产品时要轻。证实了本产品良好的解酒效果。
具体实施方式
下面结合具体实施例,对本技术方案进行详细说明,但是本发明的保护范围不局限于所述实施例。
实施例1
一种铁皮石斛花组合物,按100g质量计,所述组合物包括:
a、按所述质量比称取各种干花类原料,将各种干花类原料充分混合备用,鲜花类原料则先在60℃温度环境下,减压烘干,再按照权利要求1或2的质量比称取,混匀备用;
b、将步骤a中混合得到后的干品原料混合物用中药粉碎机进行粉碎,粉碎时间2-10分钟,过80目筛,得到混合原料干粉备用;
c、按权利要求1或2的质量比称取牛磺酸、糖粉和抗坏血酸3种原料,加入到步骤b中得到的混合原料干粉中,进行充分混合,得到铁皮石斛花组合物。
将铁皮石斛花组合物装入茶包袋后封口,每包装入1-3克,制得袋泡茶制品。
实施例2
与实施例1获得铁皮石斛花组合物的方法步骤相同,不同之处在于,将铁皮石斛花组合物灌入胶囊,每个囊粒灌入0.3克混合物,制得胶囊制品。
实施例3
与实施例1获得铁皮石斛花组合物的方法步骤相同,不同之处在于,向铁皮石斛花组合物中加入铁皮石斛花组合物本体重量的10-20%的麦芽糊精、0.1-1%的硬脂酸镁,充分混合后进行压片,制得片剂制品。
实施例4
与实施例1获得铁皮石斛花组合物的方法步骤相同,不同之处在于,向铁皮石斛花组合物中加入铁皮石斛花组合物本体重量的5-10倍量的纯净水,加热搅拌浸提30-60分钟,温度50-100℃,提取并过滤后,制得饮料制品。
实施例5
与实施例4获得铁皮石斛花组合物饮料制品的方法步骤相同,不同之处在于,将铁皮石斛花组合物饮料制品经减压浓缩后,制得口服液制品。
实施例6
与实施例4获得铁皮石斛花组合物饮料制品的方法步骤相同,不同之处在于,将铁皮石斛花组合物饮料制品经减压浓缩,进一步浓缩增稠轴,得到浸膏制品。
实施例7
与实施例1获得铁皮石斛花组合物的方法步骤相同,为实施例4或实施例6制品的延伸加工,将实施例4获得的饮料制品进行喷雾干燥或实施例6得到的浸膏制品进行冻干、粉碎,制得冲剂制品。
实施例8
一种铁皮石斛花组合物,按100g质量计,所述组合物包括:
a、按所述质量比称取各种干花类原料,将各种干花类原料充分混合备用,鲜花类原料则先在60℃温度环境下,减压烘干,再按照权利要求1或2的质量比称取,混匀备用;
b、将步骤a中混合得到后的干品原料混合物用中药粉碎机进行粉碎,粉碎时间2-10分钟,过80目筛,得到混合原料干粉备用;
c、按权利要求1或2的质量比称取牛磺酸、糖粉和抗坏血酸3种原料,加入到步骤b中得到的混合原料干粉中,进行充分混合,得到铁皮石斛花组合物。
将铁皮石斛花组合物装入茶包袋后封口,每包装入1-3克,制得袋泡茶制品。
实施例9
与实施例8获得铁皮石斛花组合物的方法步骤相同,不同之处在于,将铁皮石斛花组合物灌入胶囊,每个囊粒灌入0.3克混合物,制得胶囊制品。
实施例10
与实施例8获得铁皮石斛花组合物的方法步骤相同,不同之处在于,向铁皮石斛花组合物中加入铁皮石斛花组合物本体重量的10-20%的麦芽糊精、0.1-1%的硬脂酸镁,充分混合后进行压片,制得片剂制品。
实施例11
与实施例8获得铁皮石斛花组合物的方法步骤相同,不同之处在于,向铁皮石斛花组合物中加入铁皮石斛花组合物本体重量的5-10倍量的纯净水,加热搅拌浸提30-60分钟,温度50-100℃,提取并过滤后,制得饮料制品。
实施例12
与实施例11获得铁皮石斛花组合物饮料制品的方法步骤相同,不同之处在于,将铁皮石斛花组合物饮料制品经减压浓缩后,制得口服液制品。
实施例13
与实施例11获得铁皮石斛花组合物饮料制品的方法步骤相同,不同之处在于,将铁皮石斛花组合物饮料制品经减压浓缩,进一步浓缩增稠轴,得到浸膏制品。
实施例14
与实施例8获得铁皮石斛花组合物的方法步骤相同,为实施例11或实施例13的延伸加工,将实施例11获得的饮料制品进行喷雾干燥或实施例13得到的浸膏制品进行冻干、粉碎,制得冲剂制品。
以上所述仅是本发明的优选实施方式,应当指出:对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (5)
1.一种铁皮石斛花组合物,其特征在于:按100g质量计,所述组合物包括:
2.一种铁皮石斛花组合物,其特征在于:按100g质量计,所述组合物包括:
。
3.如权利要求1或2所述的铁皮石斛花组合物的制备方法,其特征在于:所述制备方法包括以下步骤:
a、按权利要求1或2的质量比称取各种干花类原料,将各种干花类原料充分混合备用,鲜花类原料则先在60℃温度环境下,减压烘干,再按照权利要求1或2的质量比称取,混匀备用;
b、将步骤a中混合得到后的干品原料混合物用中药粉碎机进行粉碎,粉碎时间2-10分钟,过80目筛,得到混合原料干粉备用;
c、按权利要求1或2的质量比称取牛磺酸、糖粉和抗坏血酸3种原料,加入到步骤b中得到的混合原料干粉中,进行充分混合,得到铁皮石斛花组合物。
4.根据权利要求1或2所述的铁皮石斛花组合物,其特征在于:所述铁皮石斛花、葛花、菊花、密蒙花、合欢花、槐花、栀子花、素馨花、洋金花、金银花、玫瑰花、旋覆花、三七花、桃花、桂花、木棉花及玳玳花为各种植物花的干花,没有虫蛀、腐烂特征,符合食品、药品原料要求;所述糖粉为白糖粉、红糖粉、黑糖粉及冰糖粉中的一种或者任意种的组合。
5.保肝解酒制品,包括:袋泡茶制品、胶囊制品、片剂制品、饮料制品、口服液制品、浸膏制品和冲剂制品,其特征在于:所述袋泡茶制品、胶囊制品、片剂制品、饮料制品、口服液制品、浸膏制品和冲剂制品中主要添加物为铁皮石斛花组合物;
将铁皮石斛花组合物装入茶包袋后封口,每包装入1-3克,制得袋泡茶制品;
将铁皮石斛花组合物灌入胶囊,每个囊粒灌入0.3克混合物,制得胶囊制品;
向铁皮石斛花组合物中加入铁皮石斛花组合物本体重量的10-20%的麦芽糊精、0.1-1%的硬脂酸镁,充分混合后进行压片,制得片剂制品;
向铁皮石斛花组合物中加入铁皮石斛花组合物本体重量的5-10倍量的纯净水,加热搅拌浸提30-60分钟,温度50-100℃,提取并过滤后,制得饮料制品;
将上述饮料制品经减压浓缩后,制得口服液制品,进一步浓缩增稠轴,得到浸膏制品;
将上述饮料制品进行喷雾干燥或浸膏制品进行冻干、粉碎,制得冲剂制品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610218622.0A CN105876783A (zh) | 2016-04-08 | 2016-04-08 | 一种铁皮石斛花组合物及其制法和保肝解酒制品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610218622.0A CN105876783A (zh) | 2016-04-08 | 2016-04-08 | 一种铁皮石斛花组合物及其制法和保肝解酒制品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105876783A true CN105876783A (zh) | 2016-08-24 |
Family
ID=57012869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610218622.0A Pending CN105876783A (zh) | 2016-04-08 | 2016-04-08 | 一种铁皮石斛花组合物及其制法和保肝解酒制品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105876783A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108522734A (zh) * | 2018-05-04 | 2018-09-14 | 文山学院 | 一种铁皮石斛花茶饮料及其制备方法 |
CN108902402A (zh) * | 2018-09-27 | 2018-11-30 | 张家界湘阿妹食品有限公司 | 一种葛根茶的制备方法 |
CN115715558A (zh) * | 2022-11-21 | 2023-02-28 | 淮阴工学院 | 一种解酒护肝的固体饮料及其制备方法 |
-
2016
- 2016-04-08 CN CN201610218622.0A patent/CN105876783A/zh active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108522734A (zh) * | 2018-05-04 | 2018-09-14 | 文山学院 | 一种铁皮石斛花茶饮料及其制备方法 |
CN108902402A (zh) * | 2018-09-27 | 2018-11-30 | 张家界湘阿妹食品有限公司 | 一种葛根茶的制备方法 |
CN115715558A (zh) * | 2022-11-21 | 2023-02-28 | 淮阴工学院 | 一种解酒护肝的固体饮料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102552462B (zh) | 一种泡腾制剂及其制备方法和用途 | |
CN104799146A (zh) | 一种改善亚健康的功能性营养食品组合及其制备方法 | |
CN104435775A (zh) | 一种中药保健酒及其制备方法 | |
CN102988638A (zh) | 一种青钱柳叶降脂降糖保健茶及其制备方法 | |
CN105942498A (zh) | 具有治疗糖尿病作用的功能性营养食品组合及其制备方法 | |
CN102178885B (zh) | 一种用于醒酒的药物组合物 | |
CN102657791B (zh) | 含密蒙花的中药组合物及其制备方法 | |
CN103168883A (zh) | 可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 | |
CN102293927B (zh) | 具有抗疲劳和抗氧化功能的复方中药制剂及其制备方法 | |
CN103610803B (zh) | 一种护肝解酒中药组合物 | |
CN107853517B (zh) | 一种提神抗疲劳的中药饮料及其制备方法 | |
CN104208581A (zh) | 一种预防酒精肝的五味子保健口服液及其制备方法 | |
CN106333010A (zh) | 一种袋泡减肥瘦身茶及其制备方法 | |
CN101199347A (zh) | 一种排铅保健品及其制备方法 | |
CN105876783A (zh) | 一种铁皮石斛花组合物及其制法和保肝解酒制品 | |
CN101006862A (zh) | 竹汁麦冬绞股蓝保健制剂及其生产方法 | |
CN103734767B (zh) | 一种保健食品 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN105708970A (zh) | 一种具有降血糖功能的保健食品 | |
TW200841829A (en) | Instant tea | |
CN104474472A (zh) | 具有降三高作用的苦丁茶含片及其生产方法 | |
KR20100077781A (ko) | 발기부전에 효과적인 기능성 분말의 제조 방법, 이에 의한 기능성 분말을 포함하는 기능성 보조식품 | |
KR100608456B1 (ko) | 손바닥 선인장, 오리나무, 갈근 및 헛개나무의 복합생약추출물을 함유하는 숙취해소용 조성물 | |
CN105994840A (zh) | 一种铁皮石斛降压保健茶及其制作方法 | |
CN102613648B (zh) | 一种原生态竹锗营养液的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160824 |
|
RJ01 | Rejection of invention patent application after publication |